Skip to main content

What the FDA labels say about taking them together

Carbamazepine and irinotecan

Irinotecan's FDA label of May 12, 2026 names carbamazepine in its drug interactions section; the carbamazepine labels PlainMeds reads (3) do not name irinotecan. The irinotecan label: “Avoid the use of strong CYP3A4 inducers if possible.”

Check it at the source: the carbamazepine FDA label on DailyMed (effective August 20, 2026, Novartis Pharmaceuticals Corporation); the irinotecan FDA label on DailyMed (effective May 12, 2026, Pharmacia & Upjohn Company LLC).

What does the carbamazepine label say about irinotecan?

Carbamazepine's label (effective August 20, 2026) and its 2 other brand-application labels do not name irinotecan in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tegretol), Novartis Pharmaceuticals Corporation, effective August 20, 2026 (SPL set 8d409411-aa9f-4f3a-a52c-fbcb0c3ec053), via openFDA; the full label on DailyMed

What does the irinotecan label say about carbamazepine?

Irinotecan label, drug interactions

Exposure to irinotecan or its active metabolite SN-38 is substantially reduced in adult and pediatric patients concomitantly receiving the CYP3A4 enzyme-inducing anticonvulsants phenytoin, phenobarbital, carbamazepine, or St. John's wort.

Onivyde label (Ipsen Biopharmaceuticals, Inc., March 3, 2025), drug interactions

Avoid the use of strong CYP3A4 inducers (e.g., rifampin, phenytoin, carbamazepine, rifabutin, rifapentine, phenobarbital, St. John's wort) if possible.

Source: FDA drug label (Onivyde, NDA207793), Ipsen Biopharmaceuticals, Inc., effective March 3, 2025 (SPL set c8b58efa-1820-48a4-b70d-62918fc4abfc), via openFDA

Source: FDA drug label (Camptosar), NDA020571 (Pfizer Inc), as published by Pharmacia & Upjohn Company LLC, effective May 12, 2026 (SPL set e518dfc6-7e93-4fee-a66c-51e1ab71c056), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

42Carbamazepine generic labelers
12Irinotecan generic labelers
CarbamazepineIrinotecan
Labeled forBipolar disorder, Seizures and epilepsyColorectal cancer
Boxed warningYesYes
Pharmacy cost (NADAC)$0.119 per tablet 200 mg tabletn/a
Shortage nowA presentation being discontinuedA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?